We designed this study to explore the pregnancy outcomes in women with hyperglycemia according to their prepregnancy body mass index (BMI) and to identify risk factors of poor pregnancy outcomes.
Although the gestational period is considerably short in women's lifespan, pregnancy has substantial infl uences to both mother and her offspring. Studying weight gain during pregnancy has been one of the hot topics in obstetrics for the last decades [1] [2] [3] [4] [5] . In these days overweight or obesity in women of reproductive age is rapidly increasing worldwide and they are more likely to gain excess weight during pregnancy [1] [2] [3] 6] . Overweight or obesity is considered as a common high-risk obstetric condition along with gestational diabetes, hypertensive disorder during pregnancy, op-KJOG Vol. 54, No. 10, 2011 erative delivery and poor fetal outcomes [7] [8] [9] [10] . In 2009, the American Institute of Medicine (IOM) issued guidelines for appropriate weight gain, assigning target ranges based on maternal prepregnancy body mass index (BMI). The recommended ranges of gestational weight gain are 12.5-18 kg for underweight women (BMI < 18.5 kg/m 2 ), 11.5-16.0 kg for normal weight women (BMI 18.5-24.9 kg/m 2 ), 7.0-11.5 kg for overweight women (BMI 25-29.9 kg/m 2 ), and 5.0-9.0 kg for obese women (BMI ≥ 30 kg/m 2 ) [11] . The recommended rates of weight gain during 2 nd and 3 rd trimester are 1 lb/week for underweight women, 1 lb/week for normal weight women, 0.6 lb/week for overweight women and 0.5 lb/week for obese women. Normally pregnant women are in diabetic condition during pregnancy because of their babies. The elevation of maternal glycemia is a consequence to a rise in maternal insulinemia, which facilitate fetal growth [12] . Increased maternal BMI during pregnancy and glucose status contribute to offspring birth size and birth outcomes. Although a positive association between prepregnancy BMI and disturbance in glucose metabolism has been established [13-15], it is not clearly known if prepregnancy BMI can affect the pregnancy outcomes of women with at risk of gestational diabetic condition. In this context, we designed this study to explore the pregnancy outcomes in women at risk of hyperglycemic state with respect to prepregnancy BMI and to identify the risk factors of poor pregnancy outcome.
Materials and Methods
This study used data from pregnant women whose 100 g oral glucose tolerance (OGTT) test was preformed between July 1, 2007 and December 31, 2009 at CHA Gangnam Medical Center (Seoul, Korea). Pregnant women at risk of hyperglycemia were suggested by a positive result of 50 g glucose challenge test followed by a confi rmatory 100 g fasting glucose 3-hour tolerance test (OGTT). This study was approved by the Institutional review board of CHA Medical Center, CHA University. Data of 1,215 pregnant women were collected, among which 159 participants with twin pregnancies, fetal anomalies, hypertensive disorders before pregnancy, preexisting diabetes and other diseases, and missing medical records were excluded. Prepregnancy BMI (kg/m 2 ) were calculated using self-reported prepregnancy weight and height. The participants (n = 1,056) were divided into three groups: group 1 (BMI < 18.5 kg/m 2 , n = 178); group 2 (BMI 18.5-24.9 kg/m 2 , n = 769); and group 3 (BMI ≥ 25 kg/m 2 , n = 109) according to the guidelines of World Health Organization (WHO) Asia-Pacifi c [16, 17] and considering IOM [11] . In the current study, we designated the group 3 as obese group, and other two groups as non-obese group. The overweight prepregnancy BMI in the WHO Asia-Pacifi c guidelines corresponds to normal prepregnancy BMI in the IOM guidelines. Therefore, so we grouped participants with BMI between 18.5 kg/m 2 and 25 kg/m 2 into a single group (group 2). At the first clinic visit before gestational 10 weeks, participants reported pre-pregnant weight, height and their medical history, which were double checked by their obstetricians. Gestational age was calculated based on her last menstrual period and adjusted by sonographic fi ndings at the fi rst clinic visit. Gestational weights were recorded at second trimester glycemic screening test between 24 and 28 weeks and at delivery. We examined blood pressure and urine analysis due to evaluation of pregnancy complications such as hypertension and proteinuria. Additional data were also collected on maternal age, parity, family history of diabetes or hypertension. At 24-28 weeks, all participants who had more than 140 mg/dL of 1-hour glucose level in the venous blood sample on a routine glycemic screening as a non-fasting oral glucose challenge test, underwent additional 100 g fasting glucose 3-hour tolerance test. Normal OGTT results were based on Carpenter and Coustan criteria (<95 mg/dL) at fasting state, <180 mg/dL at 1 hour, <155 mg/ dL at 2 hours, <140 mg/dL at 3 hours [18] . Gestational diabetes mellitus (GDM) was defi ned by the presence of at least two abnormal OGTT glucose values. If participating women were diagnosed with GDM, they received diet and exercise instructions, and insulin therapy, if needed. In terms of pregnancy outcomes, preterm delivery was defi ned as delivery at less than 37 weeks of gestation; macrosomia was defi ned as birth weight of 4,000 g or greater; Large for gestational age (LGA) was defi ned as birth weight more than 90 percentile; small for gestational age (SGA) was defi ned as birth weight less than 10 percentile; the conditions of primary cesarean section included from failure to progress, fetal malpresentation, and past history of uterus operation. Data were demonstrated using descriptive statistics as mean ± standard deviation and percentage in the order of group 1, group 2 and group 3 followed by P-values from statistical tests, unless otherwise stated. The differences of variables between and among groups were analyzed with Fisher's exact test and one way analysis of variance (ANOVA) test with Bonferroni post-Hoc test.
